Cardiovascular and renal disease
1 paper
Latest
7 in 12 monthsGeroScience
Effects of daily multivitamin-multimineral supplementation on metabolomic profiles: 2-year findings from the COSMOS randomized clinical trial
Randomised trial in 399 peopleInterventions
AHA Scientific Sessions 2025 Abstract
Early GLP-1 Receptor Agonist Initiation Reduces Major Cardiac and Renal Events in Older Adults with Type 2 Diabetes Without Prior Cardiovascular or Renal Disease: A Target Trial Emulation
Cohort study in peopleGLP-1 receptor agonists
AHA Scientific Sessions 2025 Abstract
Sodium–Glucose Cotransporter 2 Inhibitors are Cost-Effective and Dominate Glucagon-Like Peptide-1 Receptor Agonists for Patients with Type 2 Diabetes and High Cardiorenal Risk in Canada
Computational studySGLT2 inhibitors
ADA Scientific Sessions 2025 Abstract
Impact of SGLT2 Inhibitors with ARB or ACE Inhibitors on Cardiorenal Outcomes in Type 2 Diabetes without Preexisting Cardiovascular or Renal Disease
Cohort study of 12,339 peopleSGLT2 inhibitors
Current Cardiology Reports
Cardiovascular, renal and overall health outcomes after bariatric surgery
ReviewBariatric surgery